Phone: 959-333-0983
Phone: 959-333-0983
$54.99
This item has been third-party tested by accredited U.S. laboratories and confirmed to meet a minimum purity of 98% through rigorous verification standards.
GHRP-6 is examined in research settings as a growth hormone secretagogue peptide, interacting with the GHS-R (ghrelin receptor) to initiate receptor-mediated signaling cascades. Research involving GHRP-6 focuses on ligand–receptor binding behavior, signal initiation, and downstream intracellular communication pathways under controlled experimental conditions.
This compound is supplied exclusively for scientific and analytical research and is not intended for consumer, clinical, or therapeutic use.
$54.99
GHRP-6 (Growth Hormone–Releasing Peptide-6) is a synthetic hexapeptide supplied exclusively for laboratory and analytical research purposes. This compound is studied in controlled research environments for its interaction with growth hormone secretagogue receptors (GHS-R) and its role in peptide-mediated endocrine signaling models.
Each batch of GHRP-6 is independently third-party tested to verify identity and purity, supporting accuracy and reproducibility in scientific research applications.
GHRP-6 is studied in laboratory and preclinical research environments to better understand peptide-based activation of growth hormone secretagogue receptors. Researchers examine this compound to explore:
As a short, well-characterized peptide, GHRP-6 allows researchers to investigate receptor signaling behavior in controlled experimental models without reliance on larger or more complex peptide structures.
In experimental models, GHRP-6 binds to the growth hormone secretagogue receptor (GHS-R), a G protein–coupled receptor involved in endocrine signaling networks. Upon receptor engagement, intracellular signaling pathways associated with second-messenger activation and transcriptional regulation may be observed.
Research involving GHRP-6 focuses on mechanistic signaling behavior, including receptor activation, signal propagation, and regulatory feedback within endocrine systems. These studies do not imply physiological or clinical outcomes.
GHRP-6 supplied by ResearchChemical.com is produced under controlled peptide synthesis conditions to support compound integrity, purity, and reproducibility.
Manufacturing and verification standards include:
These measures ensure transparency and reliability for laboratory research use.
Laboratory supplies and dilution solutions are not included.
Research Chemical products are third-party tested by MZ Biolabs, an independent laboratory based in Arizona. Each batch is analyzed to ensure accuracy, purity, and that all specifications are met.
Store GHRP-6 in a cool, dry environment away from direct light. Refrigerate after reconstitution, if applicable, to maintain peptide stability. Avoid repeated freeze-thaw cycles and follow standard laboratory handling protocols to prevent contamination or degradation.
By purchasing from ResearchChemical.com, you acknowledge that you are acquiring research chemicals intended solely for scientific investigation.
GHRP-6 is:
The information provided on this page is for educational and informational purposes only and should not be interpreted as medical advice. ResearchChemical.com assumes no liability for misuse, improper handling, or use outside of controlled research environments. It is the purchaser’s responsibility to ensure compliance with all applicable laws and regulations.
GHRP-6 and Ipamorelin are both growth hormone-releasing peptides with distinct characteristics. Their effectiveness may vary depending on the specific research purpose or experimentation goal, and direct comparison studies are limited.
The laboratory experimentation of GHRP-6 has been associated with certain side effects, including increased appetite, body fat changes, and potential effects on learning and memory formation. Further laboratory experimentation is needed to fully understand its safety profile.
GHRP-6 and hGH (human growth hormone) serve different purposes and have distinct mechanisms of action. GHRP-6 acts as a growth hormone-releasing peptide, stimulating the body’s natural production of growth hormone, while hGH is a synthetic form of growth hormone directly administered for various medical purposes.
GHRP-6, a growth hormone-releasing peptide, is being studied to stimulate natural growth hormone release and promote blood vessel growth. It has been studied for its potential therapeutic applications in stroke therapy and wound healing.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Research Chemical products are third-party tested by MZ Biolabs, an independent laboratory based in Arizona. Each batch is analyzed to ensure accuracy, purity, and that all specifications are met.
By purchasing from ResearchChemical.com, you acknowledge that you are acquiring research chemicals intended solely for scientific investigation.
GHRP-6 is:
The information provided on this page is for educational and informational purposes only and should not be interpreted as medical advice. ResearchChemical.com assumes no liability for misuse, improper handling, or use outside of controlled research environments. It is the purchaser’s responsibility to ensure compliance with all applicable laws and regulations.
1. Berlanga-Acosta, J., Abreu-Cruz, A., Barco Herrera, D. G. D., Mendoza-Marí, Y., Rodríguez-Ulloa, A., García-Ojalvo, A., … & Guillén-Nieto, G. (2017). Synthetic Growth Hormone-Releasing Peptides (GHRPs): a historical appraisal of the evidences supporting their cytoprotective effects. Clinical Medicine Insights: Cardiology, 11, 1179546817694558.
2. Müller, T. D., Nogueiras, R., Andermann, M. L., Andrews, Z. B., Anker, S. D., Argente, J., … & Tschöp, M. H. (2015). Ghrelin. Molecular metabolism, 4(6), 437-460.
3. Martínez, R., Carpio, Y., Arenal, A., Lugo, J. M., Morales, R., Martín, L., … & Estrada, M. P. (2017). Significant improvement of shrimp growth performance by growth hormone‐releasing peptide‐6 immersion treatments. Aquaculture Research, 48(9), 4632-4645.
4. Primer, A. Basic Peptide. “CJC & GHRP 6.”
5. Mosa, R., Huang, L., Li, H., Grist, M., LeRoith, D., & Chen, C. (2018). Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR mice. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 314(1), R71-R83.
6. Lawrence, C. B., Snape, A. C., Baudoin, F. M. H., & Luckman, S. M. (2002). Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology, 143(1), 155-162.
7. Subirós, N., Pérez-Saad, H., Aldana, L., Gibson, C. L., Borgnakke, W. S., & Garcia-Del-Barco, D. (2016). Neuroprotective effect of epidermal growth factor plus growth hormone-releasing peptide-6 resembles hypothermia in experimental stroke. Neurological Research, 38(11), 950-958.
8. Subirós, N., Pérez-Saad, H., Aldana, L., Gibson, C. L., Borgnakke, W. S., & Garcia-Del-Barco, D. (2016). Neuroprotective effect of epidermal growth factor plus growth hormone-releasing peptide-6 resembles hypothermia in experimental stroke. Neurological Research, 38(11), 950-958.
9. Cibrián, D., Ajamieh, H., Berlanga, J., León, O. S., Alba, J. S., Kim, M. J. T., … & Playford, R. J. (2006). Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure. Clinical science, 110(5), 563-573.
10. Raben, M. S. (1962). Growth Hormone: Clinical Use of Human Growth Hormone. New England Journal of Medicine, 266(2), 82-86.
Please note that the above references provide evidence for the potential benefits of GHRP6 Peptide as stated in the product description. For more in-depth information, kindly refer to these scholarly works.
Join our insider list for the latest research insights, product releases, and special offers—delivered straight to your inbox.